- Home
- RPTX vs NMS Comparison
RPTX vs NMS Comparison
Compare RPTX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- NMS
- Stock Information
- Founded
- RPTX 2016
- NMS 1993
- Country
- RPTX Canada
- NMS United States
- Employees
- RPTX N/A
- NMS N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- RPTX Health Care
- NMS Finance
- Exchange
- RPTX Nasdaq
- NMS Nasdaq
- Market Cap
- RPTX 78.2M
- NMS 71.2M
- IPO Year
- RPTX 2020
- NMS N/A
- Fundamental
- Price
- RPTX $2.15
- NMS $11.92
- Analyst Decision
- RPTX Strong Buy
- NMS
- Analyst Count
- RPTX 3
- NMS 0
- Target Price
- RPTX $3.50
- NMS N/A
- AVG Volume (30 Days)
- RPTX 670.4K
- NMS 12.0K
- Earning Date
- RPTX 11-14-2025
- NMS 01-01-0001
- Dividend Yield
- RPTX N/A
- NMS 4.11%
- EPS Growth
- RPTX N/A
- NMS N/A
- EPS
- RPTX N/A
- NMS N/A
- Revenue
- RPTX $11,870,000.00
- NMS N/A
- Revenue This Year
- RPTX N/A
- NMS N/A
- Revenue Next Year
- RPTX N/A
- NMS N/A
- P/E Ratio
- RPTX N/A
- NMS N/A
- Revenue Growth
- RPTX N/A
- NMS N/A
- 52 Week Low
- RPTX $0.89
- NMS $9.21
- 52 Week High
- RPTX $4.07
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- RPTX 71.99
- NMS 54.99
- Support Level
- RPTX $1.65
- NMS $11.88
- Resistance Level
- RPTX $1.87
- NMS $12.07
- Average True Range (ATR)
- RPTX 0.08
- NMS 0.12
- MACD
- RPTX 0.01
- NMS 0.01
- Stochastic Oscillator
- RPTX 91.04
- NMS 75.68
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.